COG ACCL1033: A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL

Objective

This randomized phase III trial studies compliance to a mercaptopurine treatment intervention compared to standard of care in younger patients with acute lymphoblastic leukemia in remission. Assessing ways to help patients who have acute lymphoblastic leukemia to take their medications as prescribed may help them in taking their medications more consistently and may improve treatment outcomes.

https://www.clinicaltrials.gov/ct2/show/NCT01503632

Contact Phone: 218-786-3308 | 1-844-681-7944

Email: cancertrials@essentiahealth.org

Locations: Essentia Health Cancer Centers

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 06/11/2018

Research Study Categories

  • Pediatric Studies

Specialty

  • Cancer
  • Hematology